TLR4 Polyclonal Antibody | BS-20595R

(No reviews yet) Write a Review
SKU:
BS-20595R
Availability:
In Stock
Size:
100 ul
oncentration:
1ug/ul
Cross Reactive Species:
Human Mouse Rat
  • TLR4 Polyclonal Antibody | BS-20595R
  • TLR4 Polyclonal Antibody | BS-20595R
  • TLR4 Polyclonal Antibody | BS-20595R
Select Currency //354.00

 Select your currency from the header

Description

TLR4 Polyclonal Antibody | BS-20595R

Host: Rabbit

Target Protein: TLR4

Specificity: Mouse TLR4 has 75% homology to the antibody immunogen sequence

Immunogen Range: 121-200/839

Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 7099

Swiss Prot: O00206

Source: KLH conjugated synthetic peptide derived from human TLR4

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Storage: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Background:

Cooperates with LY96 and CD14 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (PubMed:9237759, PubMed:10835634). Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni2+. Responses triggered by Ni2+ require non-conserved histidines and are, therefore, species-specific (PubMed:20711192). Both M.tuberculosis HSP70 (dnaK) and HSP65 (groEL-2) act via this protein to stimulate NF-kappa-B expression (PubMed:15809303). In complex with TLR6, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion. Binds electronegative LDL (LDL-) and mediates the cytokine release induced by LDL- (PubMed:23880187).
View AllClose

0 Reviews

View AllClose